MD Anderson Cancer Center: to Enter Partnership With Xencor, Inc.
September 04, 2020
September 04, 2020
HOUSTON, Texas, Sept. 4 -- The University of Texas's MD Anderson Cancer Center issued the following news release on Sept. 3:
The University of Texas MD Anderson Cancer Center and Xencor, Inc. today announced a strategic collaboration to study investigational treatments for patients with a variety of cancer types. The parties will collaborate to design and execute additional clinical studies with Xencor's portfolio of XmAb(R) drug candidates, including novel bispecific anti . . .
The University of Texas MD Anderson Cancer Center and Xencor, Inc. today announced a strategic collaboration to study investigational treatments for patients with a variety of cancer types. The parties will collaborate to design and execute additional clinical studies with Xencor's portfolio of XmAb(R) drug candidates, including novel bispecific anti . . .